BR0206502A - Antagonistas do receptor de histamina - Google Patents

Antagonistas do receptor de histamina

Info

Publication number
BR0206502A
BR0206502A BR0206502-9A BR0206502A BR0206502A BR 0206502 A BR0206502 A BR 0206502A BR 0206502 A BR0206502 A BR 0206502A BR 0206502 A BR0206502 A BR 0206502A
Authority
BR
Brazil
Prior art keywords
histamine
receptor antagonists
receptor
histamine receptor
antagonist
Prior art date
Application number
BR0206502-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0206502A publication Critical patent/BR0206502A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0206502-9A 2001-01-17 2002-01-10 Antagonistas do receptor de histamina BR0206502A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists
PCT/IB2002/000042 WO2002056871A2 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
BR0206502A true BR0206502A (pt) 2003-10-21

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206502-9A BR0206502A (pt) 2001-01-17 2002-01-10 Antagonistas do receptor de histamina

Country Status (31)

Country Link
EP (1) EP1353657A1 (no)
JP (1) JP2004517883A (no)
KR (1) KR20030069216A (no)
CN (1) CN1486178A (no)
AP (1) AP2002002401A0 (no)
AR (1) AR032101A1 (no)
BG (1) BG107834A (no)
BR (1) BR0206502A (no)
CA (1) CA2435121A1 (no)
CR (1) CR6983A (no)
CZ (1) CZ20031853A3 (no)
DO (1) DOP2002000325A (no)
EA (1) EA200300537A1 (no)
EC (1) ECSP034692A (no)
EE (1) EE200300335A (no)
GB (1) GB0101223D0 (no)
GT (1) GT200200003A (no)
HU (1) HUP0302767A2 (no)
IL (1) IL156087A0 (no)
IS (1) IS6818A (no)
MA (1) MA26980A1 (no)
MX (1) MXPA03006408A (no)
NO (1) NO20033223L (no)
OA (1) OA12440A (no)
PA (1) PA8537101A1 (no)
PL (1) PL362793A1 (no)
SK (1) SK8572003A3 (no)
SV (1) SV2003000849A (no)
TN (1) TNSN02003A1 (no)
WO (1) WO2002056871A2 (no)
ZA (1) ZA200304180B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
EP1545596A4 (en) * 2002-09-06 2005-12-28 Janssen Pharmaceutica Nv USE OF HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ALLERGIES AND ASTHMA
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3378476A1 (en) 2012-06-08 2018-09-26 Sensorion H4 receptor inhibitors for treating tinnitus

Also Published As

Publication number Publication date
CR6983A (es) 2003-11-25
IS6818A (is) 2003-05-15
ECSP034692A (es) 2003-08-29
IL156087A0 (en) 2003-12-23
NO20033223D0 (no) 2003-07-16
GT200200003A (es) 2002-08-19
AR032101A1 (es) 2003-10-22
NO20033223L (no) 2003-07-16
ZA200304180B (en) 2004-06-15
HUP0302767A2 (hu) 2003-11-28
PL362793A1 (en) 2004-11-02
EA200300537A1 (ru) 2004-02-26
EE200300335A (et) 2003-12-15
PA8537101A1 (es) 2002-08-29
WO2002056871A2 (en) 2002-07-25
MXPA03006408A (es) 2003-10-15
MA26980A1 (fr) 2004-12-20
OA12440A (en) 2006-05-22
EP1353657A1 (en) 2003-10-22
KR20030069216A (ko) 2003-08-25
SV2003000849A (es) 2003-01-13
GB0101223D0 (en) 2001-02-28
DOP2002000325A (es) 2003-01-31
CA2435121A1 (en) 2002-07-25
TNSN02003A1 (fr) 2005-12-23
AP2002002401A0 (en) 2002-03-31
JP2004517883A (ja) 2004-06-17
CZ20031853A3 (cs) 2004-07-14
CN1486178A (zh) 2004-03-31
SK8572003A3 (en) 2004-07-07
BG107834A (bg) 2004-01-30

Similar Documents

Publication Publication Date Title
PL374024A1 (en) Terphenyl derivatives, preparation thereof, compositions containing same
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
DE60204674D1 (de) Retinoid x rezeptormodulatoren
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
HK1083838A1 (en) A2a adenosine receptor antagonists
MY117251A (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
DE69732868D1 (de) Mittel gegen Juckreiz
WO2003028641A3 (en) Mch receptor antagonists
BR0204001A (pt) Forma de dosagem oral sólida de simeticona
BRPI0409910A (pt) métodos para o tratamento de doenças relacionadas com interleucina-6
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
NO20032253L (no) Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
DE602005020655D1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonisten
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
BR0214577A (pt) Copolìmero de etileno/alfa-olefina feito com uma combinação de um catalisador de sìtio-único/sìtio-não-único, sua preparação e uso
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
AR029942A1 (es) Compuestos derivados de 1,3-dihidro-2h-indol-2-ona, su utilizacion, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden, medicamentos constituidos por dichos compuestos y compuestos intermediarios
WO2005060959A8 (en) Pyrazole derivatives and use thereof as orexin receptor antagonists
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
BR0206502A (pt) Antagonistas do receptor de histamina
DE50213012D1 (de) Polyamide-zusammensetzungen enthaltend antioxidantien

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2025 DE 27/10/2009.